Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversidade Federal Fluminense
About this trial
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).
Eligibility criteria
Qualifiers
patients with CKD undergoing hemodialysis for more than 6 months
patients with arteriovenous fistula (AVF) as vascular access.
Disqualifiers
pregnant,
lactating,
smoker
patients using antibiotics and antioxidant supplements in the last three months
Trial design
Treatments tested in this trial
- Real Jelly
- Placebo
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov